Slower titration schedules, frequent symptom tracking, and clear communication about warning signs (severe cramping, persistent vomiting, rectal bleeding) are standard best practices for this population
Only if the weight loss is prescribed to treat a documented medical condition, such as clinical obesity with a comorbidity, cardiovascular disease, or hypertension
The frequency of gastrointestinal side effects is higher with retatrutide (nausea affects about 43% vs 12-33% for Mounjaro)
That's where MDhair stands out
For those currently seeking effective weight loss treatments, its vital to know how to access safe, FDA-approved options until Retatrutide becomes available
What are the side effects of GLP-1 probiotics versus GLP-1 medications